文献速递临床试验与 GCP

维生素C与硫胺素联合治疗脓毒性休克的多中心、双盲、随机对照研究(ATESS):随机对照试验研究方案

Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-07-11

ATESS试验是一项在韩国六家急诊科开展的多中心、双盲、安慰剂对照随机试验,计划纳入116例成人脓毒性休克患者,按1:1随机分组。治疗组接受维生素C(50 mg/kg)与硫胺素(200 mg)溶于50 ml 0.9%氯化钠注射液,每12小时静脉给药一次,持续48小时;安慰剂组给予等体积0.9%氯化钠注射液。主要结局为72小时后SOFA评分变化值(ΔSOFA)。

要点

  • ATESS试验评估早期静脉维生素C联合硫胺素对脓毒性休克患者器官衰竭恢复的影响。
  • 治疗组方案为维生素C 50 mg/kg加硫胺素200 mg溶于50 ml 0.9%氯化钠注射液,每12小时静脉给药一次,共48小时。
  • 主要结局为入组时初始SOFA评分与72小时后随访SOFA评分的差值(ΔSOFA)。

核心结论

  • 该试验将为维生素C与硫胺素治疗脓毒性休克的有效性提供有价值的证据;若有效,该疗法可能改善生存并成为脓毒性休克患者的主要辅助治疗之一。

研究设计与样本

  • 随机、双盲、安慰剂对照、多中心试验,在韩国六家急诊科招募成人脓毒性休克患者。
  • 计划招募116例脓毒性休克患者,按1:1比例随机分配至治疗组或对照组(每组58例)。

主要发现

  • 治疗组:维生素C(50 mg/kg)与硫胺素(200 mg)混合于50 ml 0.9%氯化钠注射液中,每12小时静脉给药一次,共48小时。
  • 安慰剂组:给予等体积的0.9%氯化钠注射液,给药方式相同。
  • 主要结局为ΔSOFA评分(ΔSOFA = 入组时初始SOFA评分 - 72小时后随访SOFA评分)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Septic shock is a life-threatening condition with underlying circulatory and cellular/metabolic abnormalities. Vitamin C and thiamine are potential candidates for adjunctive therapy; they are expected to improve outcomes based on recent experimental and clinical research. The aim of the Ascorbic Acid and Thiamine Effect in Septic Shock (ATESS) trial is to evaluate the effects of early combination therapy with intravenous vitamin C and thiamine on recovery from organ failure in patients with septic shock. METHODS: This study is a randomized, double-blind, placebo-controlled, multicentre trial in adult patients with septic shock recruited from six emergency departments in South Korea. Patients will be randomly allocated into the treatment or control group (1:1 ratio), and we will recruit 116 septic shock patients (58 per group). For the treatment group, vitamin C (50 mg/kg) and thiamine (200 mg) will be mixed in 50 ml of 0.9% saline and administered intravenously every 12 h for a total of 48 h. For the placebo group, an identical volume of 0.9% saline will be administered in the same manner. The primary outcome is the delta Sequential Organ Failure Assessment (SOFA) score (ΔSOFA = initial SOFA at enrolment - follow-up SOFA after 72 h). DISCUSSION: This trial will provide valuable evidence about the effectiveness of vitamin C and thiamine therapy for septic shock. If effective, this therapy might improve survival and become one of the main therapeutic adjuncts for patients with septic shock. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03756220 . Registered on 5 December 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hwang SY, Park JE, Jo IJ, et al. Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial. Trials. 2019. PMID: 31296251. doi:10.1186/s13063-019-3542-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。